The Hope After Recurrence™ campaign is an educational awareness program led by the Bladder Cancer Advocacy Network (BCAN) to provide support, information and hope to survivors with recurring non-muscle invasive bladder cancer and their loved ones.
Currently there are 500,000 bladder cancer survivors in the United States, and bladder cancer is the fifth most commonly diagnosed cancer in the United States – fourth among men and 11th among women.
The majority of people (approximately 75%) diagnosed with bladder cancer are diagnosed with non-muscle invasive bladder cancer, when the cancer is highly treatable. Bladder cancer often recurs. Non-muscle invasive bladder cancer has a high likelihood of recurring.
The goal of this program is to support survivors who are facing non-muscle invasive bladder cancer recurrence by providing information on the condition, offering tools and resources, and helping them feel connected to others who are experiencing a return of their bladder cancer. This resource was developed so survivors can effectively collaborate with their doctors to help manage their condition and treatment options. In addition to printed materials available in urology and cancer centers, the Hope After Recurrence campaign offers a centralized, comprehensive online resource – www.HopeAfterRecurrence.com – with educational information to help survivors better understand and feel empowered to deal with their recurrent bladder cancer diagnosis.
This campaign is made possible with support from Endo Pharmaceuticals.